Erythropoietin recalls

The FDA has published 2 recalls involving Erythropoietin since 2017. The latest was reported on 27 Sep 2017. Most were for particulate matter. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls2since 2017
Last 12 months0reported
Class I00% of total
Ongoing0latest 27 Sep 2017

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 2 100%Class III 0 0%

Why erythropoietin is recalled

Companies

By year

All erythropoietin recalls, newest first

2 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIProcrit (epoetin alfa)/mL recalled by AmgenProcritAmgenParticulate MatterNationwide
DrugCLASS IIProcrit Epoetin Alfa/mL single use vial For Intravenouse recalledProcritAmgenParticulate MatterPR

Should you stop taking Erythropoietin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.